304 related articles for article (PubMed ID: 314300)
1. Surface phenotyping, histology and the nature of non-Hodgkin lymphoma in 157 patients.
Habeshaw JA; Catley PF; Stansfeld AG; Brearley RL
Br J Cancer; 1979 Jul; 40(1):11-34. PubMed ID: 314300
[TBL] [Abstract][Full Text] [Related]
2. Correlation of surface receptors with histological appearance in 29 cases of non-Hodgkin lymphoma.
Habeshaw JA; Macaulay RA; Stuart AE
Br J Cancer; 1977 Jun; 35(6):858-67. PubMed ID: 301396
[TBL] [Abstract][Full Text] [Related]
3. Demonstration of immunoglobulin production by tumor cells in non-Hodgkin's and Hodgkin's malignant lymphomas and its significance for their classification.
Stein H; Papadimitriou CS; Bouman H; Lennert K; Fuchs J
Recent Results Cancer Res; 1978; 64():158-75. PubMed ID: 366694
[TBL] [Abstract][Full Text] [Related]
4. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
5. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
Pinkus GS; Said JW
Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
[TBL] [Abstract][Full Text] [Related]
6. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
[TBL] [Abstract][Full Text] [Related]
7. Predictability of immunologic phenotype of malignant lymphomas by conventional morphology: a study of 60 cases.
Frizzera G; Gajl-Peczalska KJ; Bloomfield CD; Kersey JH
Cancer; 1979 Apr; 43(4):1216-24. PubMed ID: 376087
[TBL] [Abstract][Full Text] [Related]
8. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology.
Bom-Van Noorloos AA; Splinter TA; van Heerde P; van Beek AA; Melief CJ
Cancer; 1978 Oct; 42(4):1804-17. PubMed ID: 152144
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
[TBL] [Abstract][Full Text] [Related]
10. Expression of the T1 (CD5, p67) surface antigen in B-CLL and B-NHL and its correlation with other B-cell differentiation markers.
Delia D; Bonati A; Giardini R; Villa S; De Braud F; Cattoretti G; Rilke F
Hematol Oncol; 1986; 4(3):237-48. PubMed ID: 3095211
[TBL] [Abstract][Full Text] [Related]
11. Terminal deoxynucleotidyl transferase activity in lymphoma.
Habeshaw JA; Catley PF; Stansfield AG; Ganeshaguru K; Hoffbrand AV
Br J Cancer; 1979 May; 39(5):566-9. PubMed ID: 314814
[TBL] [Abstract][Full Text] [Related]
12. Benign and malignant lymphoid lesions of the stomach. A histological reappraisal in the light of the Kiel classification for non-Hodgkin's lymphomas.
Vanden Heule B; Van Kerkem C; Heimann R
Histopathology; 1979 Jul; 3(4):309-20. PubMed ID: 468132
[TBL] [Abstract][Full Text] [Related]
13. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas. An immunohistologic study of 300 cases.
Sheibani K; Winberg CD; van de Velde S; Blayney DW; Rappaport H
Am J Pathol; 1987 Apr; 127(1):27-37. PubMed ID: 3105322
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphomas: an ultrastructural study correlating morphology with immunologic cell type.
Said JW; Hargreaves HK; Pinkus GS
Cancer; 1979 Aug; 44(2):504-28. PubMed ID: 383256
[TBL] [Abstract][Full Text] [Related]
15. Canine malignant lymphomas: comparison of morphologic and immunologic parameters.
Holmberg CA; Manning JS; Osburn BI
J Natl Cancer Inst; 1976 Jan; 56(1):125-35. PubMed ID: 768497
[TBL] [Abstract][Full Text] [Related]
16. Immunologic aspects and pathology of the malignant lymphomas.
Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
Brouet JC; Labaume S; Seligmann M
Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
[TBL] [Abstract][Full Text] [Related]
18. B- and T-cell subsets in follicular centroblastic/centrocytic (cleaved follicular center cell) lymphoma: an immunohistologic analysis of 26 lymph nodes and three spleens.
Swerdlow SH; Murray LJ; Habeshaw JA; Stansfeld AG
Hum Pathol; 1985 Apr; 16(4):339-52. PubMed ID: 2579888
[TBL] [Abstract][Full Text] [Related]
19. [Clinical aspects of malignant non-Hodgkin's-lymphomas with reference to Kiel classification: centrocytic lymphoma, centroblastic-centrocytic lymphoma, lymphoblastic lymphoma, immunoblastic lymphoma].
Brittinger G; Bartels H; Bremer K; Dühmke E; Gunzer U; König E; Stein H
Hamatol Bluttransfus; 1976; 18():211-23. PubMed ID: 786810
[No Abstract] [Full Text] [Related]
20. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
Wessel H
Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
